MAKINDO MEDICINEClinical textbook for medical students and doctors
For education and revision only. Not individual medical advice; check current NICE/BNF and local guidance before clinical use. Clinical safety and terms.
Chapter 287
MAKINDO MEDICINE · Biochemistry287

Biochemistry I: carbohydrates, ATP, mitochondria and energy metabolism

Core principles: mechanisms are emphasised to explain clinical phenomena, physiological measurements and biochemical disease.

Glycolysis and pyruvate

Step / enzymeSubstrates and productsRegulation / clinical
Hexokinase / glucokinaseGlucose → glucose-6-phosphateGlucokinase in liver/beta cells has higher Km; GCK variants alter glucose sensing
Phosphofructokinase-1Fructose-6-P → fructose-1,6-bisPRate-limiting committed glycolysis; activated AMP/fructose-2,6-bisP, inhibited ATP/citrate
Pyruvate kinasePhosphoenolpyruvate → pyruvate + ATPDeficiency can cause haemolytic anaemia
Lactate dehydrogenasePyruvate ↔ lactate with NADH/NAD+ exchangeRegenerates NAD+ in anaerobic glycolysis; lactate not synonymous with tissue hypoxia
Pyruvate dehydrogenasePyruvate → acetyl-CoA + CO2 + NADHRequires thiamine, lipoate, CoA, FAD, NAD+; inhibited by acetyl-CoA/NADH

TCA cycle, respiratory chain and oxidative phosphorylation

  • Acetyl-CoA condenses with oxaloacetate via citrate synthase, then proceeds citrate → isocitrate → alpha-ketoglutarate → succinyl-CoA → succinate → fumarate → malate → oxaloacetate.
  • Per turn TCA yields 3 NADH, 1 FADH2, 1 GTP and 2 CO2; respiratory chain uses reducing equivalents to pump protons across inner mitochondrial membrane.
  • Complex I accepts NADH, complex II succinate-derived FADH2, complex III transfers electrons via cytochrome c, complex IV reduces O2 to water; ATP synthase is complex V.
  • Modern approximate ATP yield per glucose in eukaryotic cells is ~30–32 ATP depending on shuttle and tissue (rather than a fixed 36–38).
  • Uncouplers dissipate proton gradient producing heat; hypoxia impairs oxidative phosphorylation, contributing to ATP depletion and cellular dysfunction.

Gluconeogenesis and glycogen metabolism

PathwayKey steps/enzymesClinical consequence
GluconeogenesisPyruvate carboxylase, PEPCK, fructose-1,6-bisphosphatase, glucose-6-phosphataseMaintains fasting glucose in liver and kidney
GlycogenesisGlycogen synthase; branching enzymeInsulin promotes storage
GlycogenolysisGlycogen phosphorylase; debranching enzymeGlucagon (liver) and adrenaline (muscle/liver) promote mobilisation
Pentose phosphateG6PD generates NADPH and ribose-5-phosphateG6PD deficiency increases oxidative haemolysis risk
Fructose metabolismFructokinase/aldolase BHereditary fructose intolerance after fructose/sucrose exposure
Galactose metabolismGalactose-1-P uridyltransferase (GALT)Classic galactosaemia causes neonatal toxicity

Metabolic regulation across fed and fasting states

  • Fed state: high insulin/low glucagon drives glucose uptake into muscle/adipose via GLUT4, glycogen synthesis, glycolysis, lipogenesis and protein synthesis.
  • Fasting: liver glycogenolysis is initially important; gluconeogenesis becomes increasingly dominant as hepatic glycogen depletes.
  • Prolonged fasting: adipose lipolysis supplies fatty acids and glycerol, liver generates ketones, brain progressively uses ketone bodies, sparing muscle protein.
  • Skeletal muscle lacks glucose-6-phosphatase and cannot release free glucose derived from its glycogen; it produces lactate/alanine for hepatic gluconeogenesis.
End of chapter 287